Based on 5 analysts giving stock ratings to Sophia Genetics SA in the past month.
In the current month, SOPH has received 3 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. SOPH average Analyst price target in the last month is 9.750.
Based on analysts' estimates, SOPH EPS is projected to reach -0.190 in FY2026Q3, following reported EPS of -0.303 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
The market expectation was USD -0.30, while Sophia Genetics SASOPH's earnings per share (EPS) for the previous quarter was USD -0.27. EPS for the next quarter is expected at USD -0.19.